Jinling Pharmaceutical Company Limited (000919.SZ)
CNY 6.21
(0.81%)
CNY 6.21
(0.81%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.78 Billion CNY | 4.3% |
| 2022 | 2.67 Billion CNY | -4.91% |
| 2021 | 2.8 Billion CNY | 12.18% |
| 2020 | 2.5 Billion CNY | -1.23% |
| 2019 | 2.53 Billion CNY | -12.56% |
| 2018 | 2.89 Billion CNY | -9.17% |
| 2017 | 3.19 Billion CNY | -10.81% |
| 2016 | 3.57 Billion CNY | 11.09% |
| 2015 | 3.22 Billion CNY | 16.21% |
| 2014 | 2.77 Billion CNY | 6.38% |
| 2013 | 2.6 Billion CNY | 13.05% |
| 2012 | 2.3 Billion CNY | 2.12% |
| 2011 | 2.25 Billion CNY | 4.44% |
| 2010 | 2.16 Billion CNY | 9.89% |
| 2009 | 1.96 Billion CNY | 9.94% |
| 2008 | 1.78 Billion CNY | 15.49% |
| 2007 | 1.54 Billion CNY | 12.59% |
| 2006 | 1.37 Billion CNY | 11.32% |
| 2005 | 1.23 Billion CNY | 23.36% |
| 2004 | 1 Billion CNY | 17.89% |
| 2003 | 849.71 Million CNY | 34.97% |
| 2002 | 629.56 Million CNY | 26.06% |
| 2001 | 499.41 Million CNY | 36.85% |
| 2000 | 364.95 Million CNY | 3.05% |
| 1999 | 354.13 Million CNY | 4.45% |
| 1998 | 339.04 Million CNY | 12.49% |
| 1997 | 301.39 Million CNY | 53.12% |
| 1996 | 196.83 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 709.28 Million CNY | -6.52% |
| 2024 Q2 | 758.73 Million CNY | 1.64% |
| 2024 Q1 | 746.52 Million CNY | 9.54% |
| 2023 Q4 | 681.49 Million CNY | 2.81% |
| 2023 Q2 | 732.86 Million CNY | 3.43% |
| 2023 Q3 | 662.84 Million CNY | -9.55% |
| 2023 Q1 | 708.53 Million CNY | 14.81% |
| 2023 FY | 2.78 Billion CNY | 4.3% |
| 2022 Q3 | 701.67 Million CNY | 6.45% |
| 2022 Q1 | 693.01 Million CNY | -0.68% |
| 2022 Q2 | 659.16 Million CNY | -4.89% |
| 2022 FY | 2.67 Billion CNY | -4.91% |
| 2022 Q4 | 617.11 Million CNY | -12.05% |
| 2021 Q1 | 701.6 Million CNY | 2.38% |
| 2021 FY | 2.8 Billion CNY | 12.18% |
| 2021 Q4 | 697.74 Million CNY | 1.3% |
| 2021 Q2 | 720.61 Million CNY | 2.71% |
| 2021 Q3 | 688.79 Million CNY | -4.42% |
| 2020 Q2 | 629.39 Million CNY | 22.5% |
| 2020 Q4 | 685.29 Million CNY | 1.49% |
| 2020 Q3 | 675.23 Million CNY | 7.28% |
| 2020 FY | 2.5 Billion CNY | -1.23% |
| 2020 Q1 | 513.8 Million CNY | -13.64% |
| 2019 Q1 | 613.3 Million CNY | 3.55% |
| 2019 FY | 2.53 Billion CNY | -12.56% |
| 2019 Q2 | 675.83 Million CNY | 10.19% |
| 2019 Q3 | 650.83 Million CNY | -3.7% |
| 2019 Q4 | 594.94 Million CNY | -8.59% |
| 2018 FY | 2.89 Billion CNY | -9.17% |
| 2018 Q3 | 741.84 Million CNY | -4.08% |
| 2018 Q2 | 773.4 Million CNY | -2.29% |
| 2018 Q1 | 791.52 Million CNY | 9.12% |
| 2018 Q4 | 592.3 Million CNY | -20.16% |
| 2017 Q1 | 831.62 Million CNY | -10.08% |
| 2017 Q2 | 879.49 Million CNY | 5.76% |
| 2017 Q3 | 755.3 Million CNY | -14.12% |
| 2017 Q4 | 725.38 Million CNY | -3.96% |
| 2017 FY | 3.19 Billion CNY | -10.81% |
| 2016 Q1 | 870.22 Million CNY | -0.25% |
| 2016 Q4 | 924.82 Million CNY | 9.4% |
| 2016 FY | 3.57 Billion CNY | 11.09% |
| 2016 Q3 | 845.37 Million CNY | -9.9% |
| 2016 Q2 | 938.22 Million CNY | 7.81% |
| 2015 Q2 | 854.89 Million CNY | 19.91% |
| 2015 Q4 | 872.37 Million CNY | 11.68% |
| 2015 Q3 | 781.13 Million CNY | -8.63% |
| 2015 Q1 | 712.97 Million CNY | 0.09% |
| 2015 FY | 3.22 Billion CNY | 16.21% |
| 2014 FY | 2.77 Billion CNY | 6.38% |
| 2014 Q3 | 678.02 Million CNY | -9.06% |
| 2014 Q1 | 636.02 Million CNY | -11.86% |
| 2014 Q2 | 745.54 Million CNY | 17.22% |
| 2014 Q4 | 712.33 Million CNY | 5.06% |
| 2013 Q1 | 602.32 Million CNY | -4.82% |
| 2013 Q3 | 605.05 Million CNY | -10.59% |
| 2013 Q4 | 721.6 Million CNY | 19.26% |
| 2013 Q2 | 676.72 Million CNY | 12.35% |
| 2013 FY | 2.6 Billion CNY | 13.05% |
| 2012 Q2 | 619.52 Million CNY | 16.04% |
| 2012 Q3 | 518.7 Million CNY | -16.27% |
| 2012 FY | 2.3 Billion CNY | 2.12% |
| 2012 Q4 | 632.82 Million CNY | 22.0% |
| 2012 Q1 | 533.88 Million CNY | -9.72% |
| 2011 Q2 | 638.49 Million CNY | 23.43% |
| 2011 Q1 | 517.27 Million CNY | -7.28% |
| 2011 FY | 2.25 Billion CNY | 4.44% |
| 2011 Q4 | 591.37 Million CNY | 15.98% |
| 2011 Q3 | 509.88 Million CNY | -20.14% |
| 2010 Q3 | 545.1 Million CNY | -9.52% |
| 2010 Q1 | 455.67 Million CNY | -11.37% |
| 2010 Q4 | 557.88 Million CNY | 2.35% |
| 2010 FY | 2.16 Billion CNY | 9.89% |
| 2010 Q2 | 602.47 Million CNY | 32.22% |
| 2009 Q4 | 514.14 Million CNY | 20.93% |
| 2009 Q3 | 425.15 Million CNY | -21.46% |
| 2009 Q2 | 541.31 Million CNY | 11.36% |
| 2009 Q1 | 486.09 Million CNY | 8.59% |
| 2009 FY | 1.96 Billion CNY | 9.94% |
| 2008 Q1 | 406.59 Million CNY | 2.48% |
| 2008 FY | 1.78 Billion CNY | 15.49% |
| 2008 Q4 | 447.63 Million CNY | 20.01% |
| 2008 Q3 | 372.98 Million CNY | -33.59% |
| 2008 Q2 | 561.66 Million CNY | 38.14% |
| 2007 Q3 | 394.88 Million CNY | -8.54% |
| 2007 Q1 | 325.56 Million CNY | -16.88% |
| 2007 FY | 1.54 Billion CNY | 12.59% |
| 2007 Q4 | 396.76 Million CNY | 0.48% |
| 2007 Q2 | 431.76 Million CNY | 32.62% |
| 2006 Q2 | 348.65 Million CNY | 6.47% |
| 2006 Q4 | 391.67 Million CNY | 27.19% |
| 2006 Q3 | 307.93 Million CNY | -11.68% |
| 2006 Q1 | 327.46 Million CNY | 7.5% |
| 2006 FY | 1.37 Billion CNY | 11.32% |
| 2005 Q3 | 288.84 Million CNY | -20.68% |
| 2005 FY | 1.23 Billion CNY | 23.36% |
| 2005 Q2 | 364.16 Million CNY | 30.92% |
| 2005 Q1 | 278.16 Million CNY | -5.9% |
| 2005 Q4 | 304.63 Million CNY | 5.47% |
| 2004 Q3 | 213.92 Million CNY | -27.49% |
| 2004 Q2 | 295.04 Million CNY | 49.65% |
| 2004 FY | 1 Billion CNY | 17.89% |
| 2004 Q1 | 197.16 Million CNY | -23.2% |
| 2004 Q4 | 295.61 Million CNY | 38.18% |
| 2003 Q3 | 178.95 Million CNY | -26.53% |
| 2003 FY | 849.71 Million CNY | 34.97% |
| 2003 Q1 | 170.46 Million CNY | -13.88% |
| 2003 Q4 | 256.73 Million CNY | 43.47% |
| 2003 Q2 | 243.55 Million CNY | 42.88% |
| 2002 FY | 629.56 Million CNY | 26.06% |
| 2002 Q4 | 197.94 Million CNY | 54.37% |
| 2002 Q3 | 128.22 Million CNY | -36.94% |
| 2002 Q2 | 203.33 Million CNY | 103.23% |
| 2002 Q1 | 100.05 Million CNY | 0.0% |
| 2001 FY | 499.41 Million CNY | 36.85% |
| 2000 FY | 364.95 Million CNY | 3.05% |
| 1999 FY | 354.13 Million CNY | 4.45% |
| 1998 FY | 339.04 Million CNY | 12.49% |
| 1997 FY | 301.39 Million CNY | 53.12% |
| 1996 FY | 196.83 Million CNY | 0.0% |